JP2019108320A - ソフトコンタクトレンズの変質を抑制する眼科用組成物 - Google Patents

ソフトコンタクトレンズの変質を抑制する眼科用組成物 Download PDF

Info

Publication number
JP2019108320A
JP2019108320A JP2018205215A JP2018205215A JP2019108320A JP 2019108320 A JP2019108320 A JP 2019108320A JP 2018205215 A JP2018205215 A JP 2018205215A JP 2018205215 A JP2018205215 A JP 2018205215A JP 2019108320 A JP2019108320 A JP 2019108320A
Authority
JP
Japan
Prior art keywords
salt
ophthalmic composition
composition according
soft contact
contact lens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018205215A
Other languages
English (en)
Japanese (ja)
Inventor
隆司 森本
Takashi Morimoto
隆司 森本
孝司 稲垣
Koji Inagaki
孝司 稲垣
敏弘 小川
Toshihiro Ogawa
敏弘 小川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP2018205215A priority Critical patent/JP2019108320A/ja
Publication of JP2019108320A publication Critical patent/JP2019108320A/ja
Priority to CN201980071142.8A priority patent/CN112969465A/zh
Priority to PCT/JP2019/042590 priority patent/WO2020090895A1/ja
Priority to TW108139295A priority patent/TWI832920B/zh
Priority to JP2019198581A priority patent/JP6992033B2/ja
Priority to JP2021199543A priority patent/JP7429681B2/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C13/00—Assembling; Repairing; Cleaning
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
JP2018205215A 2018-10-31 2018-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物 Pending JP2019108320A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2018205215A JP2019108320A (ja) 2018-10-31 2018-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
CN201980071142.8A CN112969465A (zh) 2018-10-31 2019-10-30 抑制软性隐形眼镜变质的眼科用组合物
PCT/JP2019/042590 WO2020090895A1 (ja) 2018-10-31 2019-10-30 ソフトコンタクトレンズの変質を抑制する眼科用組成物
TW108139295A TWI832920B (zh) 2018-10-31 2019-10-30 抑制軟性隱形眼鏡變質之眼科用組成物
JP2019198581A JP6992033B2 (ja) 2018-10-31 2019-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2021199543A JP7429681B2 (ja) 2018-10-31 2021-12-08 ソフトコンタクトレンズの変質を抑制する眼科用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018205215A JP2019108320A (ja) 2018-10-31 2018-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019196886A Division JP2020070297A (ja) 2019-10-30 2019-10-30 ソフトコンタクトレンズの変質を抑制する眼科用組成物

Publications (1)

Publication Number Publication Date
JP2019108320A true JP2019108320A (ja) 2019-07-04

Family

ID=67178967

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018205215A Pending JP2019108320A (ja) 2018-10-31 2018-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2019198581A Active JP6992033B2 (ja) 2018-10-31 2019-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2021199543A Active JP7429681B2 (ja) 2018-10-31 2021-12-08 ソフトコンタクトレンズの変質を抑制する眼科用組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019198581A Active JP6992033B2 (ja) 2018-10-31 2019-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2021199543A Active JP7429681B2 (ja) 2018-10-31 2021-12-08 ソフトコンタクトレンズの変質を抑制する眼科用組成物

Country Status (4)

Country Link
JP (3) JP2019108320A (hu)
CN (1) CN112969465A (hu)
TW (1) TWI832920B (hu)
WO (1) WO2020090895A1 (hu)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021169431A (ja) * 2020-04-16 2021-10-28 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN113608363B (zh) * 2021-08-24 2023-04-14 江苏康耐特光学有限公司 一种制备高折射率树脂镜片的前弯弯度设计方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP5235420B2 (ja) * 2006-02-02 2013-07-10 株式会社メニコン ソフトコンタクトレンズ用点眼・装着液
JP6751016B2 (ja) * 2014-03-31 2020-09-02 ロート製薬株式会社 眼科用又は耳鼻科用水性組成物
CN107614018A (zh) * 2015-05-28 2018-01-19 乐敦制药株式会社 水性眼科组合物
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6940276B2 (ja) * 2016-12-26 2021-09-22 小林製薬株式会社 花粉破裂抑制剤
JP6971570B2 (ja) * 2016-12-26 2021-11-24 小林製薬株式会社 花粉破裂抑制剤
JP7313181B2 (ja) 2018-04-23 2023-07-24 ロート製薬株式会社 眼科組成物
JP7382731B2 (ja) 2018-04-23 2023-11-17 ロート製薬株式会社 眼科組成物
JP7355539B2 (ja) * 2018-07-20 2023-10-03 ロート製薬株式会社 眼科組成物
JP7458159B2 (ja) * 2018-09-28 2024-03-29 ロート製薬株式会社 眼科組成物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021169431A (ja) * 2020-04-16 2021-10-28 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2022125347A (ja) * 2020-04-16 2022-08-26 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物

Also Published As

Publication number Publication date
JP6992033B2 (ja) 2022-01-13
WO2020090895A1 (ja) 2020-05-07
TW202031263A (zh) 2020-09-01
JP7429681B2 (ja) 2024-02-08
JP2020070301A (ja) 2020-05-07
CN112969465A (zh) 2021-06-15
JP2022022379A (ja) 2022-02-03
TWI832920B (zh) 2024-02-21

Similar Documents

Publication Publication Date Title
JP7429681B2 (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP4933897B2 (ja) 眼内移行性促進水性点眼剤
JP6491588B2 (ja) ピリジルアミノ酢酸化合物を含む医薬製剤
JP6603785B2 (ja) 水溶性高分子を含む水性液剤
AU2011282683B2 (en) Preservative free brimonidine and timolol solutions
WO2017066052A1 (en) Formulations and methods for treating high intraocular pressure
JP2022185062A (ja) 点眼剤
JP6934581B2 (ja) エピナスチン又はその塩を含有する水性医薬組成物
CA3188012A1 (en) Systems and methods for preservative removal from ophthalmic formulations
JP7346305B2 (ja) ピリジルアミノ酢酸化合物を含有する医薬製剤
JP7247278B2 (ja) 水性医薬組成物
JP7114668B2 (ja) エピナスチン又はその塩を含有する花粉破裂抑制剤
CA2901208A1 (en) Topical ocular analgesic agents
JP2020070297A (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
TWI842692B (zh) 含有吡啶基胺乙酸化合物之醫藥製劑
JP2018048133A (ja) 炎症性眼疾患の治療及び／又は予防剤
US11179294B2 (en) Preservative removal from eye drops
JPH078788B2 (ja) 散瞳作用を有する眼科用医薬組成物
WO2024034592A1 (ja) Ｕｄｃａまたはその塩を含有する水性医薬組成物
WO2021210646A1 (ja) エピナスチン又はその塩を含有する水性組成物
JP2023550393A (ja) セチリジン及びトコフェルソランを含む眼科用組成物